Trial NCT04249167

View at ClinicalTrials.gov 
Org. Study IDs: MC2031
Secondary IDs: 19-008704 NCI-2020-00333

Last trial update was posted on 2023-01-06

MeSH Interventions

Albumin-Bound Paclitaxel Antibodies, Monoclonal Atezolizumab Paclitaxel

MeSH Conditions

Breast Neoplasms Carcinoma Triple Negative Breast Neoplasms

Other Conditions

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Locally Advanced Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8 Prognostic Stage IV Breast Cancer AJCC v8

Stopping Reasons

study was dropped

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID